ZophIA utilizes artificial intelligence and geometric analysis of patient speech to enhance the diagnosis of mental disorders, particularly schizophrenia, achieving 99% accuracy in pilot tests. The tool addresses the urgent need for timely and accurate mental health assessments, alleviating the burden on healthcare professionals amid rising demand for mental health services.
Funding
Funding not disclosed
Founders
Product
Problem
Diagnosing mental disorders like schizophrenia relies on subjective analyses, leading to high error rates and delayed treatment. The increasing demand for mental health services strains healthcare professionals, highlighting the need for more efficient and accurate assessment tools.
Solution
ZophIA is an AI-powered tool that analyzes patient speech using geometric analysis to aid in the diagnosis of mental disorders. By combining artificial intelligence and audio analysis, ZophIA aims to provide doctors with objective support, reducing diagnostic errors and accelerating appropriate treatment. The technology analyzes speech patterns to identify indicators of mental disorders, offering a more accurate and timely assessment compared to traditional methods. ZophIA's objective is to reduce the trauma associated with misdiagnosis or delayed diagnosis, ensuring patients receive the correct treatment sooner.
Target Audience
The primary target audience includes doctors and healthcare professionals involved in the diagnosis and treatment of mental disorders, particularly schizophrenia.
Features
- AI-driven analysis of patient speech patterns
- Geometric analysis of speech to identify indicators of mental disorders
- High accuracy in pilot testing (99% in a study with 100 patients at Hospital das Clínicas Recife)